A new controlled-release (CR) dosage formulation of albuterol has been developed which is suitable for twice-a-day dosing. The present study was conducted in twelve healthy adult male volunteers to compare the steady state plasma levels obtained following repeated administration of a 4mg C R tablet
Steady-state bioavailability of controlled-release oxycodone in normal subjects
โ Scribed by Robert F. Reder; Benjamin Oshlack; Jahanara B. Miotto; David D. Benziger; Robert F. Kaiko
- Book ID
- 117322021
- Publisher
- Elsevier Science
- Year
- 1996
- Tongue
- English
- Weight
- 687 KB
- Volume
- 18
- Category
- Article
- ISSN
- 0149-2918
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
This study was conducted to determine the relative bioavailability of Dilacorm XR capsules compared to CardizemD CD capsules at both low (180mgdPL) and high (540mgd-') dose levels. Trough and serial plasma samples were obtained and pharmacokinetic parameters were calculated from the steady state con
The steady-state pharmacokinetics of nefazodone (NEF) and its metabolites hydroxynefazodone (HO-NEF) and m-chlorophenylpiperazine (mCPP) were compared in subjects with normal and impaired renal function. Patients: The Study was of parallel group design which included 7 subjects with normal (NOR) ren